Compound Detail
CHEMBL508507
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CC(=O)N[C@@H](CCCCN)CC(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)O)C(C)(C)C
Basic Information
| ChEMBL ID | CHEMBL508507 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FBNAXOAHMCSGDO-AEYHRTIPSA-N |
1
Targets
3
Activities
3
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
845.1
MW (Da)
0.33
ALogP
10
HBA
11
HBD
311.3
PSA (Ų)
0.04
QED
2
Ro5 Violations
24
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 7.24
IC50 1 meas. best 6.74
Ki 1 meas. best 6.87
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Neurotensin receptor type 1 CHEMBL4123 | EC50 | 7.24 | 7.24 | 57.7 | 1 |
| Neurotensin receptor type 1 CHEMBL4123 | Ki | 6.87 | 6.87 | 136.0 | 1 |
| Neurotensin receptor type 1 CHEMBL4123 | IC50 | 6.74 | 6.74 | 181.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Neurotensin receptor type 1 | EC50 | = | 57.7 | nM | 7.24 | Agonist activity at NTR1 in human HT-29 cells assessed as increase in intracellu... | 19290594 |
| Neurotensin receptor type 1 | Ki | = | 136.0 | nM | 6.87 | Displacement of [125I]I-Tyr(3)NT from human NTR1 | 19290594 |
| Neurotensin receptor type 1 | IC50 | = | 181.0 | nM | 6.74 | Displacement of [125I]I-Tyr(3)NT from human NTR1 | 19290594 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19290594 | 10.1021/jm801072v | Serum | 4 |
| 19290594 | 10.1021/jm801072v | Neurotensin receptor type 1 | 3 |
| 19290594 | 10.1021/jm801072v | Rattus norvegicus | 2 |
Data from ChEMBL 36 via Core Engine